glp-1 antagonist The Agonists and Obesity: How Diabetes Drugs are Changing Non-Diabetic Lives — tl;dr pharmacy GLP-1-directed NMDA receptor antagonism for

Ex9-39 was measured using antibody 3145 raised in rabbits immunized with exendin-4, which shows 100% cross-reactivity with Ex9-39 but only 0.01% cross-reactivity with GLP-1, glucagon, and GIP (69)

For example, GLP-1s might be our best medication ever for fatty liver disease, with up to a 68% resolution, Dr

The GLP-1 landscape is evolving quickly

These medications work directly on regions of the brain involved in appetite control, such as the hypothalamus, helping you feel fuller longer, reducing hunger sensations, and curbing cravings

In an emergency, call 911 or your local emergency services.

Last reviewed: May 15, 2026 Last updated: May 15, 2026 Written by: Jay Hastings, CEO of PlexusDx Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations